Risk of subsequent endometrial carcinoma associated with endometrial intraepithelial neoplasia classification of endometrial biopsies
Open Access
- 3 October 2008
- Vol. 113 (8), 2073-2081
- https://doi.org/10.1002/cncr.23808
Abstract
BACKGROUND. Histopathologic diagnosis of endometrial biopsies is used to estimate the risk of progression to carcinoma and guide clinical management. Problems with the widely used World Health Organization (WHO) system for classifying endometrial hyperplasia (EH) have prompted the development of an alternative system based on endometrial intraepithelial neoplasia (EIN). The authors estimated progression risk associated with EIN among endometrial biopsies in a nested case‐control study of EH progression. METHODS. Index biopsies with original community pathology diagnoses of disordered proliferative endometrium (DPEM) or EH that were independently confirmed by a panel of pathologists were independently reviewed and assigned EIN classifications (inadequate, benign, EIN, or cancer) by a second panel of pathologists. Cases (N = 138) progressed to carcinoma at least 1 year (median, 6 years) after their index biopsy. Controls (N = 241) also had EH, did not progress to carcinoma, and were individually matched to cases based on age at EH, date of EH, and length of follow‐up. By using conditional logistic regression, the authors estimated relative risks (RRs) with 95% confidence intervals (95% CIs) for progression to carcinoma for EIN versus benign. RESULTS. In the EIN system, 71 (52.6%) cases and 159 (66.8%) controls were classified as benign and 42 (31.1%) cases and 65 (27.3%) controls were classified as EIN. The RR for EIN versus benign was 7.76 (95% CI, 3.36‐17.91). In the WHO system, the RR for atypical hyperplasia (AH) versus DPEM, simple hyperplasia, or complex hyperplasia was 9.19 (95% CI, 3.87‐21.83). CONCLUSIONS. Among women observed for at least 1 year after receiving a biopsy‐based EH diagnosis, EIN and AH were both found to have similarly increased risks of progression to carcinoma. Cancer 2008. © Published 2008 by American Cancer SocietyKeywords
This publication has 22 references indexed in Scilit:
- Reproducibility of Biopsy Diagnoses of Endometrial Hyperplasia: Evidence Supporting a Simplified ClassificationInternational Journal of Gynecological Pathology, 2008
- Endometrial carcinoma risk among women diagnosed with endometrial hyperplasia: the 34-year experience in a large health planBritish Journal of Cancer, 2007
- Benign Endometrial Hyperplasia Sequence and Endometrial Intraepithelial NeoplasiaInternational Journal of Gynecological Pathology, 2007
- My approach to the interpretation of endometrial biopsies and curettingsJournal of Clinical Pathology, 2006
- Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasiaCancer, 2006
- EIN and WHO94Journal of Clinical Pathology, 2005
- Limitations of the Odds Ratio in Gauging the Performance of a Diagnostic, Prognostic, or Screening MarkerAmerican Journal of Epidemiology, 2004
- Hyperplasias of the EndometriumPublished by Elsevier BV ,2004
- Conditional logistic analysis of case-control studies with complex samplingBiostatistics, 2001
- Problems in the Differential Diagnosis of Endometrial Hyperplasia and CarcinomaLaboratory Investigation, 2000